TITLE

Direct-to-consumer advertising debated in the United States and European Union

AUTHOR(S)
Guthrie, Patricia
PUB. DATE
May 2007
SOURCE
CMAJ: Canadian Medical Association Journal;5/8/2007, Vol. 176 Issue 10, p1404
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports that direct-to-consumer (DTC) advertising is being debated in the U.S. and the European Union as Canada assesses the legality of DTC drug advertising in courts. DTC advertising is not allowed in Canada but manufacturers can skirt the law by running ads that either name the drug but not its indication or communicate about the condition but do not name the drug.
ACCESSION #
25159758

 

Related Articles

  • Europe reconsidering DTCA. Meek, Colin // CMAJ: Canadian Medical Association Journal;5/8/2007, Vol. 176 Issue 10, p1405 

    The article reports that five international associations have joined forces to oppose an anticipated move by the European Commission that would give pharmaceutical companies more freedom to communicate directly with the public. The group claims that pharmaceutical companies have an inherent...

  • Stage set for Senate to shackle DTC advertisers. Teinowitz, Ira // Advertising Age;2/26/2007, Vol. 78 Issue 9, p43 

    The article states that the U.S. Senate's health committee has set a tentative date to consider legislation from Senator Ted Kennedy of Massachusetts and Senator Michael Enzi of Wyoming that could dramatically restrict direct-to-consumer advertising for prescription drugs. Advertising groups...

  • EC Takes a Second Look at Patient Information. Sheridan, Cormac // BioWorld International;10/12/2011, Vol. 16 Issue 41, p1 

    This article reports on the publication of revised proposals by the European Commission (EC) on the regulation of the flow of information between drugmakers, regulators and patients. The commission placed greater emphasis on consumer and patient rights. The changes will keep the ban on...

  • Brussels Sprouts? Pitts, Peter J. // Pharmaceutical Executive;May2006, Vol. 26 Issue 5, p50 

    The article reports on the debate about the restrictive national and European Union laws that make its illegal for pharmaceutical companies to provide any kind of information-to-patients programs (ItP). The author points out to his European colleagues that DTC advertising influences patients to...

  • DTC device ads have merit. Hempstead, Susan // Medical Marketing & Media;Jan2006, Vol. 41 Issue 1, p93 

    The article reports that the U.S. Food and Drug Administration (FDA) has sponsored a series of public meetings to solicit information and views about direct-to-consumer (DTC) promotion of prescription drug products through print, broadcast or other types of media. DTC media-product...

  • DTC advertising under scrutiny. Cameron, Amanda // New Zealand Doctor;3/22/2006, p4 

    Reports on a study which showed that New Zealand patients value direct-to-consumer (DTC) advertising for prescription medicines. Characteristics of DTC advertising that encourages consumers to seek medical advice; Concerns raised by critics of DTC advertising; Advertising code by which laws...

  • Turf War Escalates Over Big Pharma Marketing. Edwards, Jim // Brandweek;11/7/2005, Vol. 46 Issue 40, p6 

    This article focuses on the efforts of the U.S. Food and Drug Administration to review policies on direct-to-consumer (DTC) drug advertising as of November 2005. The policies were brought about by the pleas of parties wanting to ban DTC advertising. While no marketer proposed a total advertising...

  • Drug ads likely to feel pressure. Teinowitz, Ira // Advertising Age;3/18/2002, Vol. 73 Issue 11, p4 

    The article reports that industry analysts are expecting that direct-to-consumer (DTC) prescription drug advertising will come under congressional pressure in the United States during the year 2002. The need to reauthorize a prescription drug user-free act and the push to create a Medicare...

  • NOTHING BUT BLUE SKIES? Thomaselli, Rich // Advertising Age;10/2/2006, Vol. 77 Issue 40, p3 

    The article focuses on the status of direct-to-consumer (DTC) television advertising from drug companies in the U.S. Since the Food and Drug Administration's decision to relax the guidelines regarding DTC advertisements, the category has emerged from a dawdling $12 million business to a $4.1...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics